Codexis Inc. [CDXS] stock prices are down -8.79% to $4.20 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDXS shares have gain 31.41% over the last week, with a monthly amount glided 52.36%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results. In a post published today on Yahoo Finance, Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID™.
From an analyst’s perspective:
Codexis Inc. [NASDAQ: CDXS] stock has seen the most recent analyst activity on February 29, 2024, when The Benchmark Company upgraded its rating to a Buy. Previously, The Benchmark Company downgraded its rating to Hold on November 07, 2023. On August 07, 2023, downgrade downgraded it’s rating to Market Perform and revised its price target to $4 on the stock. H.C. Wainwright downgraded its rating to a Neutral. In a note dated April 12, 2021, Piper Sandler initiated an Overweight rating and provided a target price of $32 on this stock.
The stock price of Codexis Inc. [CDXS] has been fluctuating between $1.45 and $5.07 over the past year. Codexis Inc. [NASDAQ: CDXS] shares were valued at $4.20 at the most recent close of the market.
Analyzing the CDXS fundamentals
The Codexis Inc. [NASDAQ:CDXS] reported sales of 70.14M for trailing twelve months, representing a drop of -12.56%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -1.06%, Pretax Profit Margin comes in at -1.1%, and Net Profit Margin reading is -1.1%. To continue investigating profitability, this company’s Return on Assets is posted at -4.08, Equity is -0.76 and Total Capital is 4.95. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.03 points at the first support level, and at 3.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.54, and for the 2nd resistance point, it is at 4.88.
Codexis Inc. [CDXS] reported earnings per share of -$0.1 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.12/share, meaning a difference of $0.02 and a surprise factor of 16.70%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.5 per share as compared to estimates of -$0.32 per share, a difference of -$0.18 representing a surprise of -56.20%.
Ratios To Look Out For
It’s worth pointing out that Codexis Inc. [NASDAQ:CDXS]’s Current Ratio is 2.61. Also, the Quick Ratio is 2.53, while the Cash Ratio stands at 1.82. Considering the valuation of this stock, the price to sales ratio is 4.21, the price to book ratio is 3.39.
Transactions by insiders
Recent insider trading involved Dorgan Byron L, Director, that happened on Nov 15 when 20000.0 shares were sold. Chief Operating Officer, Norrett Kevin completed a deal on Sep 11 to buy 9000.0 shares. Meanwhile, DILLY STEPHEN GEORGE bought 58479.0 shares on Sep 08.
